Testing effectiveness (Phase 2)Active Not RecruitingNCT02331498
What this trial is testing
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Who this might be right for
Glioblastoma Multiforme
Centre Antoine Lacassagne 51